Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pneumococcal Conjugate Vaccine (PCV) Schedules for the Northern Territory (NT): Randomised Controlled Trial of Booster Vaccines to Broaden and Strengthen Protection From Invasive and Mucosal Infections.

X
Trial Profile

Pneumococcal Conjugate Vaccine (PCV) Schedules for the Northern Territory (NT): Randomised Controlled Trial of Booster Vaccines to Broaden and Strengthen Protection From Invasive and Mucosal Infections.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
  • Indications Otitis media; Pneumococcal infections; Respiratory tract infections
  • Focus Pharmacodynamics
  • Acronyms PREV-IX_B; PREV-IX_BOOST
  • Most Recent Events

    • 01 Sep 2022 Results (n=261; Between April 10, 2013, and Sept 4, 2018) assessing the immunogenicity of novel pneumococcal conjugate vaccine (PCV) schedules from PREVIX_COMBO and PREVIX_BOOST randomised controlled trials, published in The Lancet Infectious Diseases.
    • 23 Mar 2020 Status changed from active, no longer recruiting to completed.
    • 17 Oct 2018 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top